Tag Archive | "asset purchase"

Zogenix sells Zohydro franchise to Pernix

Tags: , ,


Pernix Ireland, a wholly owned subsidiary of Pernix Therapeutics has signed a definitive agreement to acquire the Zohydro ER franchise from Zogenix Read the full story

Concordia Healthcare stumps up $1.2bn for Covis Pharma assets

Tags: , ,


Concordia Healthcare has entered into a definitive asset purchase agreement to acquire substantially all of the commercial assets of privately held Covis Pharma and Covis Injectables for US$1.2 billion Read the full story

Arrowhead acquires Novartis RNAi R&D portfolio

Tags: , , ,


Arrowhead Research announced the acquisition of Novartis' entire RNAi research and development portfolio and associated assets Read the full story

Boston Scientific acquire men’s health and prostate businesses from Endo

Tags: ,


Boston Scientific will acquire Endo's American Medical Systems' (AMS) Men's and Prostate Health businesses for up to $1.65 billion Read the full story

Sun acquires GSKs opiates business

Tags: , , ,


GlaxoSmithKline and Sun Pharmaceutical have reached an agreement related to GSK’s Opiates business in Australia Read the full story

Cardinal Health agrees to acquire Cordis from J&J

Tags: , ,


Big pharma giant Johnson & Johnson has found a buyer for its Cordis unit, a manufacturer of cardiology and endovascular devices, which it put on the market in August 2014 . Read the full story

Endo International sells urology portfolio to Boston Scientific

Tags: , ,


Endo International is selling its men’s health and prostate urology businesses to Boston Scientific Corp. for $1.6 billion, as it attempts to refocus its efforts on more lucrative parts of its portfolio and regain revenue after a rocky 2014. Read the full story

Mayne acquires Doryx rights from Actavis

Tags: , , , ,


Actavis has entered into an agreement with Mayne Pharma, under which it will divest the U.S. rights to the Doryx Read the full story

Emergent acquires Eisai’s EV-035 series technology

Tags: , , ,


Evolva Holding announced that Emergent BioSolutions has acquired Evolva’s anti-bacterial programme, the EV-035 series Read the full story

Abbvie reinforces API capabilities in Asia

Tags: , , ,


AbbVie has acquired a small molecule active pharmaceutical ingredient (API) manufacturing site in Singapore's Tuas Biomedical Park Read the full story